[
    [
        {
            "time": "2018-03-15",
            "original_text": "Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?",
            "features": {
                "keywords": [
                    "VanEck",
                    "Vectors",
                    "Pharmaceutical",
                    "ETF",
                    "PPH"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 9,
                "Source_Recency": 2
            }
        },
        {
            "time": "2018-03-15",
            "original_text": "Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus",
            "features": {
                "keywords": [
                    "Pharma",
                    "AZN",
                    "RHHBY",
                    "Cancer",
                    "Drugs",
                    "LLY",
                    "BMY",
                    "Deals"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-03-15",
            "original_text": "Today's Research Reports on Trending Tickers: Bristol-Myers Squibb and Novartis",
            "features": {
                "keywords": [
                    "Research",
                    "Reports",
                    "Trending",
                    "Tickers",
                    "Bristol-Myers",
                    "Squibb",
                    "Novartis"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]